322 results on '"Diez-Domingo, Javier"'
Search Results
2. Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: A population-based, retrospective cohort study
3. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis
4. Adverse events in pregnant women with the tetravalent influenza vaccine obtained from cell cultures
5. Acontecimientos adversos en embarazadas con la vacuna tetravalente contra la gripe obtenida de cultivos celulares
6. Evolution of informed consent in research: From the Hippocratic Oath to the tailored consent
7. Incidence of herpes zoster and its complications in ≥ 50-year-old Spanish adults: A prospective cohort study
8. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
9. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents
10. Healthcare Professionals' Perspectives on HPV Recommendations: Themes of Interest to Different Population Groups and Strategies for Approaching Them.
11. Epidemiological and clinical insights into the enterovirus D68 upsurge in Europe 2021/22 and the emergence of novel B3-derived lineages, ENPEN multicentre study
12. Economic evaluation of meningococcal vaccines: considerations for the future
13. Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
14. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
15. Digital tools in the informed consent process: a systematic review
16. Assessment of the appropriateness of the i-CONSENT guidelines recommendations for improving understanding of the informed consent process in clinical studies
17. Experts’ opinion for improving global adolescent vaccination rates: a call to action
18. What have we learnt about rotavirus in Spain in the last 10 years?
19. ¿Qué hemos aprendido sobre rotavirus en España en los últimos 10 años?
20. Drivers for human papillomavirus vaccination in Valencia (Spain)
21. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination
22. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative
23. Correction to: Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
24. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season
25. Vacunas para proteger a nuestros mayores: eficiencia, responsabilidad y ética
26. Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network
27. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
28. Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination
29. Antibiotic Use in Children – A Cross-National Analysis of 6 Countries
30. Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial
31. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial
32. Rotavirus, vaccine failure or diagnostic error?
33. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations
34. Age differences in comorbidities, presenting symptoms, and outcomes of influenza illness requiring hospitalization: A worldwide perspective from the global influenza hospital surveillance network
35. Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine
36. Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers
37. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial
38. 114. Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination
39. Co‐creation of information materials within the assent process: From theory to practice
40. Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
41. Keys to improving the informed consent process in research: Highlights of the i‐CONSENT project
42. A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants
43. Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population
44. SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine
45. Co‐creation of information materials within the assent process: From theory to practice.
46. Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - An ACCESS Cohort Study
47. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021
48. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021
49. Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
50. Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.